Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-011857
Filing Date
2022-08-03
Accepted
2022-08-03 16:02:20
Documents
101
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q icpt-20220630x10q.htm   iXBRL 10-Q 2322831
2 EX-10.1 icpt-20220630xex10d1.htm EX-10.1 972770
3 EX-10.2 icpt-20220630xex10d2.htm EX-10.2 640995
4 EX-10.3 icpt-20220630xex10d3.htm EX-10.3 400487
5 EX-10.4 icpt-20220630xex10d4.htm EX-10.4 320698
6 EX-10.5 icpt-20220630xex10d5.htm EX-10.5 213183
7 EX-10.6 icpt-20220630xex10d6.htm EX-10.6 385285
8 EX-10.7 icpt-20220630xex10d7.htm EX-10.7 70873
9 EX-10.8 icpt-20220630xex10d8.htm EX-10.8 74189
10 EX-10.9 icpt-20220630xex10d9.htm EX-10.9 47647
11 EX-10.10 icpt-20220630xex10d10.htm EX-10.10 59922
12 EX-10.11 icpt-20220630xex10d11.htm EX-10.11 126223
13 EX-10.12 icpt-20220630xex10d12.htm EX-10.12 197760
14 EX-10.13 icpt-20220630xex10d13.htm EX-10.13 143157
15 EX-10.14 icpt-20220630xex10d14.htm EX-10.14 206804
16 EX-10.15 icpt-20220630xex10d15.htm EX-10.15 68554
17 EX-10.16 icpt-20220630xex10d16.htm EX-10.16 109565
18 EX-31.1 icpt-20220630xex31d1.htm EX-31.1 9879
19 EX-31.2 icpt-20220630xex31d2.htm EX-31.2 9862
20 EX-32.1 icpt-20220630xex32d1.htm EX-32.1 10342
  Complete submission text file 0001558370-22-011857.txt   14878767

Data Files

Seq Description Document Type Size
21 EX-101.SCH icpt-20220630.xsd EX-101.SCH 56801
22 EX-101.CAL icpt-20220630_cal.xml EX-101.CAL 83042
23 EX-101.DEF icpt-20220630_def.xml EX-101.DEF 270295
24 EX-101.LAB icpt-20220630_lab.xml EX-101.LAB 512612
25 EX-101.PRE icpt-20220630_pre.xml EX-101.PRE 444408
95 EXTRACTED XBRL INSTANCE DOCUMENT icpt-20220630x10q_htm.xml XML 2316767
Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

EIN.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35668 | Film No.: 221132446
SIC: 2834 Pharmaceutical Preparations